A GFP endometriosis model reveals important morphological characteristics of the angiogenic process that govern benign and malignant diseases.
This study established a GFP endometriosis model in mice, revealing similar angiogenic patterns to cancer, with increased vascularization, Vegf, and macrophage infiltration, providing a platform for further endometriosis and anti-angiogenic drug research.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The paper uses a GFP-based mouse endometriosis model to study angiogenesis and lesion morphology, by transplanting endometrial fragments from GFP-mice into the peritoneal cavity of wild-type recipient mice and then analyzing tissue structure and vascular changes. Lesions formed cystic, vascularized tissue with endometrial glands and stroma, and immunostaining and RNAm analyses showed increased vascular density alongside elevated VEGF and its receptor Flk-1, with GFP-labeled fluorescent cells confirming the donor origin. Activated macrophages were also more abundant in the lesions (about a 25% increase by flow cytometry), aligning with an inflammatory–angiogenic link reported in prior work, and the authors note a key limitation that this is an in vivo model designed for studying angiogenesis patterns rather than fully recapitulating all aspects of human disease. This paper is centrally about endometriosis — it establishes and characterizes a GFP endometriosis model focusing on the morphological features and markers of angiogenesis and macrophage-associated inflammation.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
2,928 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (10)
- Transgenic mice applications in the study of endometriosis pathogenesis 2024
- Targeted Imaging of Endometriosis and Image-Guided Resection of Lesions Using Gonadotropin-Releasing Hormone Analogue-Modified Indocyanine Green 2023
- Endometriosis in the Mouse: Challenges and Progress Toward a ‘Best Fit’ Murine Model 2022
- Inhibition of erythropoietin‐producing hepatoma receptor B4 (EphB4) signalling suppresses the vascularisation and growth of endometriotic lesions 2020
- Vascularization of endometrial tissue in abdominal cavity – the most important link in the pathogenesis of endometriosis or its vulnerable spot in terms of treatment? (review of literature) 2019
- The effects of certain angioneogenesis inhibitors in experimental endometriosis in rats 2019
- Basic mechanisms of vascularization in endometriosis and their clinical implications 2018
- Endometriosis: where are we and where are we going? 2016
- Impaired Development of Early Endometriotic Lesions in CD44 Knockout Mice 2015
- Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis 2015
Source provenance
- europepmc
- last seen: 2026-07-26T06:08:39.051465+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:18:40.923139+00:00